S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
Log in

TSE:APHA - Aphria Stock Price, Forecast & News

C$6.54
+0.14 (+2.19 %)
(As of 01/28/2020 04:00 PM ET)
Today's Range
C$6.34
Now: C$6.54
C$6.64
50-Day Range
C$6.10
MA: C$6.67
C$7.58
52-Week Range
C$4.95
Now: C$6.54
C$14.37
Volume3.93 million shs
Average Volume4.39 million shs
Market CapitalizationC$1.65 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-427-4742

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$448.41 million
Cash FlowC$1.70 per share
Book ValueC$6.84 per share

Profitability

Miscellaneous

Employees300
Market CapC$1.65 billion
Next Earnings DateN/A
OptionableOptionable

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.


Aphria (TSE:APHA) Frequently Asked Questions

What is Aphria's stock symbol?

Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."

What price target have analysts set for APHA?

4 brokerages have issued 12 month price targets for Aphria's stock. Their forecasts range from C$7.00 to C$16.00. On average, they expect Aphria's stock price to reach C$9.90 in the next twelve months. This suggests a possible upside of 51.4% from the stock's current price. View Analyst Price Targets for Aphria.

What is the consensus analysts' recommendation for Aphria?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.

Has Aphria been receiving favorable news coverage?

News stories about APHA stock have been trending somewhat negative this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aphria earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Aphria.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aurora Cannabis (ACB), KushCo (KSHB), OrganiGram (OGI), CannTrust (CTST), NVIDIA (NVDA), HEXO (HEXO) and Abattis Bioceuticals (ATT).

Who are Aphria's key executives?

Aphria's management team includes the folowing people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, VP of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Brett D. Marchand, Sr. VP of Operations

How do I buy shares of Aphria?

Shares of APHA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately C$6.54.

How big of a company is Aphria?

Aphria has a market capitalization of C$1.65 billion and generates C$448.41 million in revenue each year. Aphria employs 300 workers across the globe.View Additional Information About Aphria.

What is Aphria's official website?

The official website for Aphria is http://www.aphria.com/.

How can I contact Aphria?

Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.


MarketBeat Community Rating for Aphria (TSE APHA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  356 (Vote Outperform)
Underperform Votes:  322 (Vote Underperform)
Total Votes:  678
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel